Cell and Gene Therapy Bio-Manufacturing Market Size is valued at 13.8 billion in 2024 and is predicted to reach 40.2 billion by the year 2031 at an 11.4% CAGR during the forecast period for 2025-2034.
The global cell and gene therapy bio-manufacturing market is advancing. The cell and gene therapy industry is rapidly expanding due to its promise to cure chronic and rare/orphan diseases that previously had few therapeutic choices. The development of sophisticated medicines has been critical in redefining the treatment paradigm of various life-threatening and uncommon diseases, as well as in reshaping the biopharmaceutical sector. The rapid expansion of the advanced therapy landscape is a key driver of the cell and gene therapy manufacturing market.
However, due to its unprecedented scale and severity, the COVID-19 epidemic has significantly disrupted social, economic, and political activities all around the world. As a result, COVID-19 has upset the cell and gene therapy (CGT) sector, which has historically suffered from considerable complexity in the supply of materials, production, and logistical operations.
The cell and gene therapy bio-manufacturing market is segmented on the basis of product type, usage, application, and end-user. Based on product type, the market is categorized as consumables, equipment, and software solutions. The usage segment includes commercial-stage manufacturing and research-stage manufacturing. By application, the market is segmented into upstream processing, harvesting, and downstream processing. The end-user segment includes life science companies, contract research organizations (CROs), contract manufacturing organizations (CMOs), and cell banks.
The commercial stage manufacturing segment category is expected to hold a considerable share in the global cell and gene therapy bio-manufacturing Market in 2024. As the number of regulatory approvals for gene and cell therapy products grows, so does the demand for commercial production of these medicines. To meet shifting industry demands, key market players such as Thermo Fisher Scientific and AGC Biologics are launching a number of strategic initiatives. For example, Thermo Fisher Scientific will launch new Patheon Commercial Packaging Services for cell and gene therapy in the United States and Europe in February 2022. This comprehensive solution integrates logistics, serialization compliance, and global distribution. Such characteristics are predicted to provide a favorable environment for segment expansion.
The contract manufacturing organizations segment is projected to grow at a rapid rate in the global cell and gene therapy bio-manufacturing market. With rising demand for cell and gene therapies, a need for manufacturing capacity is opening up new prospects for contract manufacturing service providers. Due to the non-standardized and frequently changing nature of the cell and gene therapy sector, outsourcing to a contract manufacturing service provider is likely to provide a competitive advantage in terms of experience and competence.
The North America Cell and Gene Therapy Bio-manufacturing Market is expected to register the highest market share in terms of revenue in the near future. This can be attributed to the region's rising involvement in gene and cell therapy research and product development, as well as a large number of contract development businesses. Also, domestic firms are increasing their production operations in the region. Asia Pacific is expected to be a rising market for the production of cell and gene therapies. Cell treatment has gained traction in Asia during the last few years. This is due to the introduction of expedited approval procedures, increased healthcare requirements, and increased commercial and government spending.
| Report Attribute | Specifications |
| Market size value in 2024 | USD 13.8 Bn |
| Revenue forecast in 2034 | USD 40.2 Bn |
| Growth rate CAGR | CAGR of 11.4% from 2025 to 2034 |
| Quantitative units | Representation of revenue in US$ Billion, and CAGR from 2025 to 2034 |
| Historic Year | 2021 to 2024 |
| Forecast Year | 2025-2034 |
| Report coverage | The forecast of revenue, the position of the company, the competitive market statistics, growth prospects, and trends |
| Segments covered | Product Type, Usage, Application, And End-User |
| Regional scope | North America; Europe; Asia Pacific; Latin America; Middle East & Africa |
| Country scope | U.S.; Canada; U.K.; Germany; China; India; Japan; Brazil; Mexico; The UK; France; Italy; Spain; South Korea; Southeast Asia |
| Competitive Landscape | Becton, Dickinson and Company, Bio-Rad Laboratories, Inc., Bio-Techne Corporation, Danaher Corporation, Endress+Hauser Group Services AG (Analytik Jena GmbH), General Electric Company (G.E. Healthcare), Getinge AB, Infors AG, Lonza Group Ltd, Merck KGaA, Miltenyi Biotec B.V. & Co. K.G., PIERRE GUERIN, Sartorius AG (Sartorius Stedim Biotech S.A.), Thermo Fisher Scientific Inc., and WuXi AppTec. |
| Customization scope | Free customization report with the procurement of the report, Modifications to the regional and segment scope. Particular Geographic competitive landscape. |
| Pricing and available payment methods | Explore pricing alternatives that are customized to your particular study requirements. |
Chapter 1. Methodology and Scope
1.1. Research Methodology
1.2. Research Scope & Assumptions
Chapter 2. Executive Summary
Chapter 3. Global Cell and Gene Therapy Biomanufacturing Market Snapshot
Chapter 4. Global Cell and Gene Therapy Biomanufacturing Market Variables, Trends & Scope
4.1. Market Segmentation & Scope
4.2. Drivers
4.3. Challenges
4.4. Trends
4.5. Investment and Funding Analysis
4.6. Industry Analysis – Porter’s Five Forces Analysis
4.7. Competitive Landscape & Market Share Analysis
4.8. Impact of Covid-19 Analysis
Chapter 5. Market Segmentation 1: by Product Estimates & Trend Analysis
5.1. by Product & Market Share, 2024 & 2034
5.2. Market Size (Value (US$ Mn)) & Forecasts and Trend Analyses, 2021 to 2034 for the following by Product:
5.2.1. Consumables
5.2.1.1. Culture Supplements
5.2.1.1.1. Media
5.2.1.1.2. Serum
5.2.1.1.3. Macronutrients
5.2.1.2. Single-Use Liquids
5.2.1.3. Cell Culture Reagents
5.2.1.4. Cell Quantification Kits
5.2.2. Equipment
5.2.2.1. Bioreactors/Fermenters
5.2.2.1.1. Continuous Bioreactors
5.2.2.1.2. Single-Use Bioreactors
5.2.2.2. Mixing Systems
5.2.2.3. Cell Counters
5.2.2.4. Cell Sorters
5.2.2.5. Centrifuges
5.2.2.6. Incubators
5.2.2.7. Biosafety Cabinets
5.2.2.8. Freezers
5.2.2.9. PCR Systems
5.2.2.10. Transfection Systems
5.2.2.11. Storage Tanks
5.2.2.12. Others
5.2.3. Software Solutions
Chapter 6. Market Segmentation 2: by Usage Estimates & Trend Analysis
6.1. by Usage & Market Share, 2024 & 2034
6.2. Market Size (Value (US$ Mn)) & Forecasts and Trend Analyses, 2021 to 2034 for the following by Usage:
6.2.1. Commercial Stage Manufacturing
6.2.2. Research Stage Manufacturing
Chapter 7. Market Segmentation 3: by Application Estimates & Trend Analysis
7.1. by Application & Market Share, 2024 & 2034
7.2. Market Size (Value (US$ Mn)) & Forecasts and Trend Analyses, 2021 to 2034 for the following by Application:
7.2.1. Upstream Processing
7.2.1.1. Formulation and Hydration
7.2.1.2. Cell Culture Processing
7.2.2. Harvesting
7.2.3. Downstream Processing
7.2.3.1. Separation and Filtration
7.2.3.2. Fill and Finish Operations
Chapter 8. Market Segmentation 4: by End-user Estimates & Trend Analysis
8.1. by End-user & Market Share, 2024 & 2034
8.2. Market Size (Value (US$ Mn)) & Forecasts and Trend Analyses, 2021 to 2034 for the following by End-user:
8.2.1. Life Science Companies
8.2.1.1. Equipment
8.2.1.2. Consumables
8.2.1.3. Software Solutions
8.2.2. Contract Research Organizations (CROs)
8.2.2.1. Equipment
8.2.2.2. Consumables
8.2.2.3. Software Solutions
8.2.3. Contract Manufacturing Organizations (CMOs)
8.2.3.1. Equipment
8.2.3.2. Consumables
8.2.3.3. Software Solutions
8.2.4. Cell Banks
8.2.4.1. Equipment
8.2.4.2. Consumables
8.2.4.3. Software Solutions
Chapter 9. Cell and Gene Therapy Biomanufacturing Market Segmentation 5: Regional Estimates & Trend Analysis
9.1. North America
9.1.1. North America Cell and Gene Therapy Biomanufacturing Market Revenue (US$ Million) Estimates and Forecasts by Product, 2021-2034
9.1.2. North America Cell and Gene Therapy Biomanufacturing Market Revenue (US$ Million) Estimates and Forecasts by Usage, 2021-2034
9.1.3. North America Cell and Gene Therapy Biomanufacturing Market Revenue (US$ Million) Estimates and Forecasts by Application, 2021-2034
9.1.4. North America Cell and Gene Therapy Biomanufacturing Market Revenue (US$ Million) Estimates and Forecasts by End-user, 2021-2034
9.1.5. North America Cell and Gene Therapy Biomanufacturing Market Revenue (US$ Million) Estimates and Forecasts by country, 2021-2034
9.2. Europe
9.2.1. Europe Cell and Gene Therapy Biomanufacturing Market Revenue (US$ Million) Estimates and Forecasts by Product, 2021-2034
9.2.2. Europe Cell and Gene Therapy Biomanufacturing Market Revenue (US$ Million) Estimates and Forecasts by Usage, 2021-2034
9.2.3. Europe Cell and Gene Therapy Biomanufacturing Market Revenue (US$ Million) Estimates and Forecasts by Application, 2021-2034
9.2.4. Europe Cell and Gene Therapy Biomanufacturing Market Revenue (US$ Million) Estimates and Forecasts by End-user, 2021-2034
9.2.5. Europe Cell and Gene Therapy Biomanufacturing Market Revenue (US$ Million) Estimates and Forecasts by country, 2021-2034
9.3. Asia Pacific
9.3.1. Asia Pacific Cell and Gene Therapy Biomanufacturing Market Revenue (US$ Million) Estimates and Forecasts by Product, 2021-2034
9.3.2. Asia Pacific Cell and Gene Therapy Biomanufacturing Market Revenue (US$ Million) Estimates and Forecasts by Usage, 2021-2034
9.3.3. Asia-Pacific Cell and Gene Therapy Biomanufacturing Market Revenue (US$ Million) Estimates and Forecasts by Application, 2021-2034
9.3.4. Asia-Pacific Cell and Gene Therapy Biomanufacturing Market Revenue (US$ Million) Estimates and Forecasts by End-user, 2021-2034
9.3.5. Asia Pacific Cell and Gene Therapy Biomanufacturing Market Revenue (US$ Million) Estimates and Forecasts by country, 2021-2034
9.4. Latin America
9.4.1. Latin America Cell and Gene Therapy Biomanufacturing Market Revenue (US$ Million) Estimates and Forecasts by Product, 2021-2034
9.4.2. Latin America Cell and Gene Therapy Biomanufacturing Market Revenue (US$ Million) Estimates and Forecasts by Usage, 2021-2034
9.4.3. Latin America Cell and Gene Therapy Biomanufacturing Market Revenue (US$ Million) Estimates and Forecasts by Application, 2021-2034
9.4.4. Latin America Cell and Gene Therapy Biomanufacturing Market Revenue (US$ Million) Estimates and Forecasts by End-user, 2021-2034
9.4.5. Latin America Cell and Gene Therapy Biomanufacturing Market Revenue (US$ Million) Estimates and Forecasts by country, 2021-2034
9.5. Middle East & Africa
9.5.1. Middle East & Africa Cell and Gene Therapy Biomanufacturing Market Revenue (US$ Million) Estimates and Forecasts by Product, 2021-2034
9.5.2. Middle East & Africa Cell and Gene Therapy Biomanufacturing Market Revenue (US$ Million) Estimates and Forecasts by Usage, 2021-2034
9.5.3. Middle East & Africa Cell and Gene Therapy Biomanufacturing Market Revenue (US$ Million) Estimates and Forecasts by Application, 2021-2034
9.5.4. Middle East & Africa Cell and Gene Therapy Biomanufacturing Market Revenue (US$ Million) Estimates and Forecasts by End-user, 2021-2034
9.5.5. Middle East & Africa Cell and Gene Therapy Biomanufacturing Market Revenue (US$ Million) Estimates and Forecasts by country, 2021-2034
Chapter 10. Competitive Landscape
10.1. Major Mergers and Acquisitions/Strategic Alliances
10.2. Company Profiles
10.2.1. Becton, Dickinson and Company
10.2.2. Endress+Hauser Group Services AG (Analytik Jena GmbH)
10.2.3. Danaher Corporation
10.2.4. Bio-Rad Laboratories, Inc.
10.2.5. Bio-Techne Corporation
10.2.6. General Electric Company (G.E. Healthcare)
10.2.7. Getinge AB
10.2.8. Infors AG
10.2.9. Lonza Group Ltd
10.2.10. Merck KGaA
10.2.11. Miltenyi Biotec B.V. & Co. KG
10.2.12. PIERRE GUERIN
10.2.13. Sartorius AG (Sartorius Stedim Biotech S.A.)
10.2.14. Thermo Fisher Scientific Inc.
10.2.15. WuXi AppTec
10.2.16. Other Prominent Players
Cell and Gene Therapy Bio-manufacturing Market By Product Type-
Cell and Gene Therapy Bio-manufacturing Market By Usage-
Cell and Gene Therapy Bio-manufacturing Market By Application-
Cell and Gene Therapy Bio-manufacturing Market By End-User-
Cell and Gene Therapy Bio-manufacturing Market By Region-
North America-
Europe-
Asia-Pacific-
Latin America-
Middle East & Africa-